Report Detail
Global Transdermal Testosterone Market Insights, Forecast to 2025
- RnM3536405 |
- 17 June, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Transdermal Testosterone contains testosterone. It is used for hormone replacement in men who are not able to produce enough testosterone (e.g., hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels.
The global Transdermal Testosterone market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Transdermal Testosterone market based on company, product type, end user and key regions.
This report studies the global market size of Transdermal Testosterone in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Transdermal Testosterone in these regions.
This research report categorizes the global Transdermal Testosterone market by top players/brands, region, type and end user. This report also studies the global Transdermal Testosterone market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AbbVie
Teva
Perrigo
Endo Pharmaceuticals
Acerus Pharmaceuticals
Lupin
Dr. Reddy's Laboratories
Upsher-Smith Laboratories
Allergan
Cipla Inc.
Market size by Product
Gel
Patch
Solution
Market size by End User
Primary hypogonadism
Hypogonadotropic hypogonadism
Late-onset hypogonadism
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Transdermal Testosterone market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Transdermal Testosterone market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Transdermal Testosterone companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Transdermal Testosterone submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Transdermal Testosterone are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Transdermal Testosterone market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Transdermal Testosterone Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Transdermal Testosterone Market Size Growth Rate by Product
- 1.4.2 Gel
- 1.4.3 Patch
- 1.4.4 Solution
- 1.5 Market by End User
- 1.5.1 Global Transdermal Testosterone Market Size Growth Rate by End User
- 1.5.2 Primary hypogonadism
- 1.5.3 Hypogonadotropic hypogonadism
- 1.5.4 Late-onset hypogonadism
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Transdermal Testosterone Market Size
- 2.1.1 Global Transdermal Testosterone Revenue 2014-2025
- 2.1.2 Global Transdermal Testosterone Sales 2014-2025
- 2.2 Transdermal Testosterone Growth Rate by Regions
- 2.2.1 Global Transdermal Testosterone Sales by Regions
- 2.2.2 Global Transdermal Testosterone Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Transdermal Testosterone Sales by Manufacturers
- 3.1.1 Transdermal Testosterone Sales by Manufacturers
- 3.1.2 Transdermal Testosterone Sales Market Share by Manufacturers
- 3.1.3 Global Transdermal Testosterone Market Concentration Ratio (CR5 and HHI)
- 3.2 Transdermal Testosterone Revenue by Manufacturers
- 3.2.1 Transdermal Testosterone Revenue by Manufacturers (2014-2019)
- 3.2.2 Transdermal Testosterone Revenue Share by Manufacturers (2014-2019)
- 3.3 Transdermal Testosterone Price by Manufacturers
- 3.4 Transdermal Testosterone Manufacturing Base Distribution, Product Types
- 3.4.1 Transdermal Testosterone Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Transdermal Testosterone Product Type
- 3.4.3 Date of International Manufacturers Enter into Transdermal Testosterone Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Transdermal Testosterone Sales by Product
- 4.2 Global Transdermal Testosterone Revenue by Product
- 4.3 Transdermal Testosterone Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Transdermal Testosterone Breakdown Data by End User
6 North America
- 6.1 North America Transdermal Testosterone by Countries
- 6.1.1 North America Transdermal Testosterone Sales by Countries
- 6.1.2 North America Transdermal Testosterone Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Transdermal Testosterone by Product
- 6.3 North America Transdermal Testosterone by End User
7 Europe
- 7.1 Europe Transdermal Testosterone by Countries
- 7.1.1 Europe Transdermal Testosterone Sales by Countries
- 7.1.2 Europe Transdermal Testosterone Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Transdermal Testosterone by Product
- 7.3 Europe Transdermal Testosterone by End User
8 Asia Pacific
- 8.1 Asia Pacific Transdermal Testosterone by Countries
- 8.1.1 Asia Pacific Transdermal Testosterone Sales by Countries
- 8.1.2 Asia Pacific Transdermal Testosterone Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Transdermal Testosterone by Product
- 8.3 Asia Pacific Transdermal Testosterone by End User
9 Central & South America
- 9.1 Central & South America Transdermal Testosterone by Countries
- 9.1.1 Central & South America Transdermal Testosterone Sales by Countries
- 9.1.2 Central & South America Transdermal Testosterone Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Transdermal Testosterone by Product
- 9.3 Central & South America Transdermal Testosterone by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Transdermal Testosterone by Countries
- 10.1.1 Middle East and Africa Transdermal Testosterone Sales by Countries
- 10.1.2 Middle East and Africa Transdermal Testosterone Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Transdermal Testosterone by Product
- 10.3 Middle East and Africa Transdermal Testosterone by End User
11 Company Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Company Details
- 11.1.2 Company Business Overview
- 11.1.3 AbbVie Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 AbbVie Transdermal Testosterone Products Offered
- 11.1.5 AbbVie Recent Development
- 11.2 Teva
- 11.2.1 Teva Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Teva Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Teva Transdermal Testosterone Products Offered
- 11.2.5 Teva Recent Development
- 11.3 Perrigo
- 11.3.1 Perrigo Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Perrigo Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Perrigo Transdermal Testosterone Products Offered
- 11.3.5 Perrigo Recent Development
- 11.4 Endo Pharmaceuticals
- 11.4.1 Endo Pharmaceuticals Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Endo Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Endo Pharmaceuticals Transdermal Testosterone Products Offered
- 11.4.5 Endo Pharmaceuticals Recent Development
- 11.5 Acerus Pharmaceuticals
- 11.5.1 Acerus Pharmaceuticals Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Acerus Pharmaceuticals Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Acerus Pharmaceuticals Transdermal Testosterone Products Offered
- 11.5.5 Acerus Pharmaceuticals Recent Development
- 11.6 Lupin
- 11.6.1 Lupin Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Lupin Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Lupin Transdermal Testosterone Products Offered
- 11.6.5 Lupin Recent Development
- 11.7 Dr. Reddy's Laboratories
- 11.7.1 Dr. Reddy's Laboratories Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Dr. Reddy's Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Dr. Reddy's Laboratories Transdermal Testosterone Products Offered
- 11.7.5 Dr. Reddy's Laboratories Recent Development
- 11.8 Upsher-Smith Laboratories
- 11.8.1 Upsher-Smith Laboratories Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Upsher-Smith Laboratories Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Upsher-Smith Laboratories Transdermal Testosterone Products Offered
- 11.8.5 Upsher-Smith Laboratories Recent Development
- 11.9 Allergan
- 11.9.1 Allergan Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Allergan Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Allergan Transdermal Testosterone Products Offered
- 11.9.5 Allergan Recent Development
- 11.10 Cipla Inc.
- 11.10.1 Cipla Inc. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Cipla Inc. Transdermal Testosterone Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Cipla Inc. Transdermal Testosterone Products Offered
- 11.10.5 Cipla Inc. Recent Development
12 Future Forecast
- 12.1 Transdermal Testosterone Market Forecast by Regions
- 12.1.1 Global Transdermal Testosterone Sales Forecast by Regions 2019-2025
- 12.1.2 Global Transdermal Testosterone Revenue Forecast by Regions 2019-2025
- 12.2 Transdermal Testosterone Market Forecast by Product
- 12.2.1 Global Transdermal Testosterone Sales Forecast by Product 2019-2025
- 12.2.2 Global Transdermal Testosterone Revenue Forecast by Product 2019-2025
- 12.3 Transdermal Testosterone Market Forecast by End User
- 12.4 North America Transdermal Testosterone Forecast
- 12.5 Europe Transdermal Testosterone Forecast
- 12.6 Asia Pacific Transdermal Testosterone Forecast
- 12.7 Central & South America Transdermal Testosterone Forecast
- 12.8 Middle East and Africa Transdermal Testosterone Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Transdermal Testosterone Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Transdermal Testosterone . Industry analysis & Market Report on Transdermal Testosterone is a syndicated market report, published as Global Transdermal Testosterone Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Transdermal Testosterone market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
